Fawzy Rasha Mohamed, Hashaad Nashwa Ismail, Mansour Amira Ibrahim
Department of Rheumatology, Rehabilitation & Physical Medicine, Benha University School of Medicine, Benha, Egypt.
Department of Clinical and Chemical Pathology, Benha University School of Medicine, Benha, Egypt.
Eur J Rheumatol. 2017 Jun;4(2):93-97. doi: 10.5152/eurjrheum.2017.160076. Epub 2017 Jun 1.
This study aimed to evaluate the effect of one dose of intra-articular injection of (PRP) in the knee joint on a specific osteoarthritis (OA) serum biomarker of cartilage degeneration, Collagen 2-1 (Coll2-1), over a short period of 3 months. The aim extended to clarify the effect of PRP on the functional status of the osteoarthritic knee joint.
Sixty patients with primary unilateral knee OA were enrolled in this study. They were subdivided according to Kellgren-Lawrence grading scale (KL) into (Group I): including patients with KL grade < 3 and (Group II): including patients with KL grade ≥3. Patients were asked to complete the Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score. PRP was prepared and injected immediately into the affected knee. Serum Coll2-1 (S.Coll2-1) concentration was measured by enzyme-linked immunosorbent assay (ELISA) kit pre and 3 months after PRP injection.
Significant reduction in S.Coll2-1 concentration in primary knee OA patients; (p<0.001) and (p<0.05) in group I and group II respectively as well as significant improvements in WOMAC total and WOMAC sub-scores values were noted after single intra-articular PRP injection with maximal functional improvements were achieved after 3 months (p<0.001). Mild cases experienced favorable results with no remarkable adverse reactions were observed.
Reduction in specific OA biomarker S.Coll2-1 following intra-articular PRP injection emphasize that PRP could be a promising safe and tolerable effective therapeutic option which improves function from basal states in primary knee OA patients.
本研究旨在评估膝关节内注射一剂富血小板血浆(PRP)在3个月的短时间内对软骨退变的特定骨关节炎(OA)血清生物标志物——胶原蛋白2-1(Coll2-1)的影响。该目的还扩展到阐明PRP对骨关节炎膝关节功能状态的影响。
60例原发性单侧膝关节OA患者纳入本研究。根据凯尔格伦-劳伦斯分级量表(KL)将他们分为(I组):包括KL分级<3的患者和(II组):包括KL分级≥3的患者。要求患者完成西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分。制备PRP并立即注射到患膝中。在PRP注射前和注射后3个月,通过酶联免疫吸附测定(ELISA)试剂盒测量血清Coll2-1(S.Coll2-1)浓度。
原发性膝关节OA患者的S.Coll2-1浓度显著降低;I组和II组分别为(p<0.001)和(p<0.05),并且在单次关节内注射PRP后,WOMAC总分和WOMAC子评分值有显著改善,3个月后实现了最大功能改善(p<0.001)。轻度病例取得了良好效果,未观察到明显不良反应。
关节内注射PRP后特定OA生物标志物S.Coll2-1的降低强调,PRP可能是一种有前景的安全且耐受性良好的有效治疗选择,可改善原发性膝关节OA患者的基础功能状态。